|  Help  |  About  |  Contact Us

Publication : Cross-Regulation of Two Type I Interferon Signaling Pathways in Plasmacytoid Dendritic Cells Controls Anti-malaria Immunity and Host Mortality.

First Author  Yu X Year  2016
Journal  Immunity Volume  45
Issue  5 Pages  1093-1107
PubMed ID  27793594 Mgi Jnum  J:258326
Mgi Id  MGI:6112074 Doi  10.1016/j.immuni.2016.10.001
Citation  Yu X, et al. (2016) Cross-Regulation of Two Type I Interferon Signaling Pathways in Plasmacytoid Dendritic Cells Controls Anti-malaria Immunity and Host Mortality. Immunity 45(5):1093-1107
abstractText  Type I interferon (IFN) is critical for controlling pathogen infection; however, its regulatory mechanisms in plasmacytoid cells (pDCs) still remain unclear. Here, we have shown that nucleic acid sensors cGAS-, STING-, MDA5-, MAVS-, or transcription factor IRF3-deficient mice produced high amounts of type I IFN-alpha and IFN-beta (IFN-alpha/beta) in the serum and were resistant to lethal plasmodium yoelii YM infection. Robust IFN-alpha/beta production was abolished when gene encoding nucleic acid sensor TLR7, signaling adaptor MyD88, or transcription factor IRF7 was ablated or pDCs were depleted. Further, we identified SOCS1 as a key negative regulator to inhibit MyD88-dependent type I IFN signaling in pDCs. Finally, we have demonstrated that pDCs, cDCs, and macrophages were required for generating IFN-alpha/beta-induced subsequent protective immunity. Thus, our findings have identified a critical regulatory mechanism of type I IFN signaling in pDCs and stage-specific function of immune cells in generating potent immunity against lethal YM infection.
Quick Links:
 
Quick Links:
 

Expression

Publication --> Expression annotations

 

Other

46 Bio Entities

Trail: Publication

0 Expression